Search results for: England
Filter search results
Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Five Questions We Think Matter a Lot
29 March 2019
…considered, especially in the world of medical devices and equipment oftentimes excluded from price benchmarking and evidence conversations. Not dissimilar to the ECRI model, NHS England set up a database…
OHE Lunchtime Seminar: Closing the ‘Know-do’ Gap for Health Systems Reform at the Policy Level
5 September 2019
…large-scale changes in selected countries (Sweden, England, Spain, and Portugal). Sharing all lessons learnt from across European experiences will help health systems across Europe and beyond to make faster progress…
Making Outcome-based Payment a Reality in the NHS: Moving to the Next Phase
3 October 2019
…for some cancer medicines into the NHS in England, and identified the treatment outcomes that people affected by cancer consider most important. The first phase of the study ‘Making Outcome-Based…
Chronic Diseases and the Stock of Health: Quantification Using EQ-5D-5L
15 October 2019
…An EQ-5D-5L value set for England. Health Economics, 27(1), pp.7–22. DOI. RePEc. Feng, Y., Devlin, N., Bateman, A., Zamora, B. and Parkin, D., 2019. Distribution of the EQ-5D-5L Profiles and…
Are Cost-Effectiveness Thresholds Fit for Purpose for Real-World Decision Making on Access to and Pricing of Pharmaceuticals? A New OHE Paper on Current Methods and Practices, and a Novel Approach for Optimal Thresholds
3 March 2020
…A., 2019. Exploring variations in the opportunity cost cost-effectiveness threshold by clinical area: Results from a feasibility study in England. OHE Research Paper 18/07. Available at https://www.ohe.org/publications/exploring-variations-opportunity-cost-cost-effectiveness-threshold-clinical-area Hernandez-Villafuerte, K., Zamora,…
How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.
26 March 2020
…payments for new antibiotics from the volumes used. The UK proposals by NICE and NHS England have the overall objective to put in place a subscription model for purchasing antibiotics…
The Digitalisation of Health Care During COVID-19: Consideration of the Long-Term Consequences
28 April 2020
…has been an increase in attention towards the potential of digital technologies in the health care space as they offer a means of addressing this problem: for example, in England…
OHE Awarded Independent Research Organisation (IRO) Status by UKRI
20 May 2020
…we have been awarded Independent Research Organisation (IRO) status. This has been granted by UK Research and Innovation (UKRI), which – through the seven Research Councils, Innovate UK and Research England –…
OHE Authors Develop a Supply and Demand Model of Pharmaceutical Markets to Set Cost-Effectiveness Thresholds to Maximise and Distribute Social Welfare
15 June 2020
…from a feasibility study in England. OHE Research Paper 18/07. Hernandez-Villafuerte, K., Zamora, B. and Towse, A., 2018. Issues Surrounding the Estimation of the Opportunity Cost of Adopting a New…